Bill
HR 8339
Drug Origin Transparency Act of 2026
119th Congress
Introduced by Dan Crenshaw and 3 co-sponsors
The act requires drug labels and reports to reveal original manufacturers and all supply-chain suppliers for APIs, with detailed origin data and more frequent reporting.
Introduced in House